跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,621 条关于
“Mezzion Pharma”
全部
9,621
临床试验
4,107
药物
1,113
机构
1,221
资讯
3,180
4个月前
Mezzion Secures Strategic Financing to Advance Phase 3 Trial of Udenafil for Fontan Circulation
去年
Mezzion Secures $20 Million to Advance Phase 3 Trial of Udenafil for Rare Congenital Heart Disease
上个月
Mezzion Reports Positive In Vivo Results for PDE5 Inhibitor Udenafil in ADPKD, Plans Phase 2b Trial
9个月前
Mezzion Secures Key U.S. Patent for Udenafil in Fontan Patients, Extending Exclusivity to Early 2040s
上个月
Royalty Pharma and Zealand Pharma enter $100 million rusfertide funding agreement
去年
FDA Approves Verona Pharma's Ohtuvayre (ensifentrine) for COPD Maintenance
去年
Nxera Pharma Partners with Holling Bio-Pharma to Launch Daridorexant for Insomnia in Taiwan
去年
Calluna Pharma Appoints Mark Gaffney as CEO, Advances CAL101 Program
上个月
Fierce Pharma Week Europe Launches in Basel for 2027, Targeting Cross-Functional Pharma Leadership
去年
Fabhalta Demonstrates Sustained Efficacy in Phase III C3 Glomerulopathy Trial
第 1 页,共 318 页
上一页
下一页